Skip to main content
Figure 3 | BMC Urology

Figure 3

From: Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder

Figure 3

Dot-plots for presentation of the best marker combinations to distinguish between healthy persons (black dots) and bladder cancer patients (open dots). A: Ratio of MMP2 to TIMP1 versus MMP2; B: mROC combination of MMP9+TIMP1 versus MMP2; C: mROC combination of MMP2+MMP9+TIMP1 versus MMP2. The dashed lines indicate the cutoff values for 95% sensitivity of MMP2 and the corresponding marker combinations.

Back to article page